1-4 of 4
L. Jeffrey Medeiros, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Simultaneous Targeting of SHH/ p53 Pathways in Large B Cell Lymphomas.

Nikhil S Chari, Ph.D., Albert E.K. Teo, BS, L. Jeffrey Medeiros, M.D., Timothy J. McDonnell, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1730.
https://doi.org/10.1182/blood.V114.22.1730.1730
Published: 2009
Journal Articles

Massive Mobilization of AML Cells into Circulation by Disruption of Leukemia/Stroma Cell Interactions Using CXCR4 Antagonist AMD3100: First Evidence in Patients and Potential for Abolishing Bone Marrow Microenvironment-Mediated Resistance.

Michael Andreeff, MD, PhD, Sergej Konoplev, M.D., Ph.D., Rui-Yu Wang, M.D., Ph.D., Zhihong Zeng, Ph.D., Teresa McQueen, Yue-Xi Shi, L. Jeffrey Medeiros, M.D., Elihu Estey, M.D., John M. McCarty, M.D., Stephanie Elkins, M.D., Richard Champlin, M.D., Gary Calandra, M.D., Ph.D., Gary Bridger, Ph.D., Marina Konopleva, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 568.
https://doi.org/10.1182/blood.V108.11.568.568
Published: 2006
Journal Articles

Blastoid Mantle Cell Lymphoma (MCL): 5-yr Failure-Free Survival (FFS) Rate of 50%, without Failures after 2.5 Years Following Treatment with Rituximab (R)-HyperCVAD Alternating with R-Methotrexate/Cytarabine (M/A).

Jorge Enrique Romaguera, MD, Luis Fayad, M.D., Maria Alma Rodriguez, M.D., F.B. Hagemeister, M.D., Barbara Pro, M.D., Peter McLaughlin, M.D., Anas Younes, M.D., Felipe Samaniego, M.D., Andre Goy, M.D., Andreas H. Sarris, M.D., Nam H. Dang, M.D., Luhua Wang, M.D., Hagop M. Kantarjian, M.D., Virginia Beasley, L. Jeffrey Medeiros, M.D., Ruth L. Katz, M.D., Fernando Cabanillas, M.D.
Journal: Blood
Blood (2006) 108 (11): 2749.
https://doi.org/10.1182/blood.V108.11.2749.2749
Published: 2006
Journal Articles

Results of Rituximab Plus ABVD in 65 Newly Diagnosed Patients with Classical Hodgkin Lymphoma: Improvement of Event Free Survival (EFS) in All International Prognostic Score (IPS) Groups.

Anas Younes, MD, Luis Y. Fayad, M.D., Andre Goy, M.D., Peter McLaughlin, M.D., Barbara Pro, M.D., Jorge Romaguera, M.D., Fredrick Hagemeister, M.D., Maria A. Rodriguez, M.D., Felipe Samaniego, M.D., Larry Kwak, M.D.Ph.D., Sattva Neelapu, M.D., L. Jeffrey Medeiros, M.D., Amanda Wedgwood, R.N., Michelle Fanale, M.D.
Journal: Blood
Blood (2006) 108 (11): 2742.
https://doi.org/10.1182/blood.V108.11.2742.2742
Published: 2006